WHAT WE DO
We are Developing a novel molecule class for multiple Disease indications
Relay Life Science offers a novel model for developing therapeutics and positions them for rapid, high value acquisition by a commercial partner.
Experienced team of founders and advisory board members
Initial studies have shown strong efficacy of our molecule class in treating a range of health issues
Broad range of potential indications mitigates risk for investors (various target diseases, multiple exit opportunities, etc.)
Multiple development inflection points offer opportunity for exit anywhere between early clinical trials and commercialization